Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Wall Street
Price Targets
Price Targets Summary
Shanghai Fosun Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Fosun Pharmaceutical Group Co Ltd is 30.54 CNY with a low forecast of 24.75 CNY and a high forecast of 39.9 CNY.
Revenue
Forecast
Revenue Estimate
Shanghai Fosun Pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.
Operating Income
Forecast
Operating Income Estimate
Shanghai Fosun Pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 28%.
Net Income
Forecast
Net Income Estimate
Shanghai Fosun Pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 18%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Shanghai Fosun Pharmaceutical Group Co Ltd's stock price target?
Price Target
30.54
CNY
According to Wall Street analysts, the average 1-year price target for Shanghai Fosun Pharmaceutical Group Co Ltd is 30.54 CNY with a low forecast of 24.75 CNY and a high forecast of 39.9 CNY.
What is Shanghai Fosun Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
8%
For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's revenue is 16%. The projected CAGR for the next 3 years is 8%.
What is Shanghai Fosun Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
28%
For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's operating income is -1%. The projected CAGR for the next 3 years is 28%.
What is Shanghai Fosun Pharmaceutical Group Co Ltd's Net Income forecast?
Projected CAGR
18%
For the last 8 years the compound annual growth rate for Shanghai Fosun Pharmaceutical Group Co Ltd's net income is 0%. The projected CAGR for the next 3 years is 18%.